HUNG-CHIH YANGJIA-HORNG KAO2021-07-122021-07-1220200929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087736569&doi=10.1016%2fj.jfma.2020.07.007&partnerID=40&md5=e3d81589ba60f762895979eb49c203ffhttps://scholars.lib.ntu.edu.tw/handle/123456789/570823[SDGs]SDG3antivirus agent; hepatitis B surface antigen; hepatitis vaccine; hepatitis vaccine; antiviral therapy; health care policy; hepatitis B; Hepatitis B virus; hepatitis C; Hepatitis C virus; human; nonhuman; patient care; Short Survey; Taiwan; Taiwanese; vaccination; viral clearance; virus hepatitis; virus transmission; World Health Organization; disease eradication; hepatitis B; hepatitis C; history; male; Disease Eradication; Hepatitis B; Hepatitis C; History, 20th Century; History, 21st Century; Humans; Male; Taiwan; Viral Hepatitis Vaccinesshort survey10.1016/j.jfma.2020.07.007326548672-s2.0-85087736569